CFG
PDLI

Citizens Financial Group’s PDL BioPharma, Inc. PDLI Stock Holding History

Citizens Financial Group’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,162
Closed -$12K – 1086
2020
Q2 		$12K Buy
+4,162
New +$13.2K ﹤0.01% 744

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citizens Financial Group's PDLI Position: Q3 2020 in Review

Citizens Financial Group sold out of PDL BioPharma, Inc. (PDLI) in Q3 2020, closing a stake of 4,162 shares — an estimated $12K sold.

Citizens Financial Group first reported a position in PDLI in Q2 2020 and held it in 1 quarter. The position peaked at $12K in Q2 2020. 132 funds tracked by Wall St. Rank hold PDLI as of Q3 2020.

  • Citizens Financial Group reported no remaining PDL BioPharma, Inc. position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 4,162 PDL BioPharma, Inc. shares in Q3 2020, an estimated $12K.
  • Citizens Financial Group first reported a position in PDL BioPharma, Inc. in Q2 2020 and held it in 1 quarter.
  • Citizens Financial Group's PDL BioPharma, Inc. position peaked at $12K in Q2 2020.
  • 132 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.